447 related articles for article (PubMed ID: 11160455)
1. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.
Volkow ND; Wang G; Fowler JS; Logan J; Gerasimov M; Maynard L; Ding Y; Gatley SJ; Gifford A; Franceschi D
J Neurosci; 2001 Jan; 21(2):RC121. PubMed ID: 11160455
[TBL] [Abstract][Full Text] [Related]
2. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
Volkow ND; Wang GJ; Fowler JS; Logan J; Franceschi D; Maynard L; Ding YS; Gatley SJ; Gifford A; Zhu W; Swanson JM
Synapse; 2002 Mar; 43(3):181-7. PubMed ID: 11793423
[TBL] [Abstract][Full Text] [Related]
3. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain.
Volkow ND; Wang GJ; Fowler JS; Telang F; Maynard L; Logan J; Gatley SJ; Pappas N; Wong C; Vaska P; Zhu W; Swanson JM
Am J Psychiatry; 2004 Jul; 161(7):1173-80. PubMed ID: 15229048
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of methylphenidate: insights from PET imaging studies.
Volkow ND; Fowler JS; Wang G; Ding Y; Gatley SJ
J Atten Disord; 2002; 6 Suppl 1():S31-43. PubMed ID: 12685517
[TBL] [Abstract][Full Text] [Related]
5. Decreases in dopamine receptors but not in dopamine transporters in alcoholics.
Volkow ND; Wang GJ; Fowler JS; Logan J; Hitzemann R; Ding YS; Pappas N; Shea C; Piscani K
Alcohol Clin Exp Res; 1996 Dec; 20(9):1594-8. PubMed ID: 8986209
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain.
Tsukada H; Harada N; Nishiyama S; Ohba H; Kakiuchi T
J Neurosci; 2000 Sep; 20(18):7067-73. PubMed ID: 10995853
[TBL] [Abstract][Full Text] [Related]
7. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.
Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Logan J; Ding YS; Hitzemann R; Pappas N
Am J Psychiatry; 1998 Oct; 155(10):1325-31. PubMed ID: 9766762
[TBL] [Abstract][Full Text] [Related]
8. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
Volkow ND; Wang GJ; Newcorn J; Telang F; Solanto MV; Fowler JS; Logan J; Ma Y; Schulz K; Pradhan K; Wong C; Swanson JM
Arch Gen Psychiatry; 2007 Aug; 64(8):932-40. PubMed ID: 17679638
[TBL] [Abstract][Full Text] [Related]
9. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies.
Volkow ND; Fowler JS; Wang GJ; Ding YS; Gatley SJ
Eur Neuropsychopharmacol; 2002 Dec; 12(6):557-66. PubMed ID: 12468018
[TBL] [Abstract][Full Text] [Related]
10. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
Tsukada H; Harada N; Nishiyama S; Ohba H; Sato K; Fukumoto D; Kakiuchi T
Synapse; 2000 Aug; 37(2):95-103. PubMed ID: 10881030
[TBL] [Abstract][Full Text] [Related]
11. Methylphenidate-evoked potentiation of extracellular dopamine in the brain of adolescents with premature birth: correlation with attentional deficit.
Rosa Neto P; Lou H; Cumming P; Pryds O; Gjedde A
Ann N Y Acad Sci; 2002 Jun; 965():434-9. PubMed ID: 12105118
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma.
Volkow ND; Wang GJ; Fowler JS; Molina PE; Logan J; Gatley SJ; Gifford A; Ding YS; Wong C; Pappas NR; Zhu W; Swanson JM
Psychopharmacology (Berl); 2003 Mar; 166(3):264-70. PubMed ID: 12589522
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR
J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065
[TBL] [Abstract][Full Text] [Related]
14. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.
Graff-Guerrero A; Willeit M; Ginovart N; Mamo D; Mizrahi R; Rusjan P; Vitcu I; Seeman P; Wilson AA; Kapur S
Hum Brain Mapp; 2008 Apr; 29(4):400-10. PubMed ID: 17497628
[TBL] [Abstract][Full Text] [Related]
15. Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain.
Volkow ND; Wang GJ; Telang F; Fowler JS; Logan J; Wong C; Ma J; Pradhan K; Tomasi D; Thanos PK; Ferré S; Jayne M
J Neurosci; 2008 Aug; 28(34):8454-61. PubMed ID: 18716203
[TBL] [Abstract][Full Text] [Related]
16. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
[TBL] [Abstract][Full Text] [Related]
17. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.
Dresel S; Krause J; Krause KH; LaFougere C; Brinkbäumer K; Kung HF; Hahn K; Tatsch K
Eur J Nucl Med; 2000 Oct; 27(10):1518-24. PubMed ID: 11083541
[TBL] [Abstract][Full Text] [Related]
18. Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studies.
Koochesfahani KM; de la Fuente-Fernández R; Sossi V; Schulzer M; Yatham LN; Ruth TJ; Blinder S; Stoessl AJ
Mov Disord; 2006 Jul; 21(7):970-5. PubMed ID: 16570297
[TBL] [Abstract][Full Text] [Related]
19. Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain.
Volkow ND; Wang GJ; Logan J; Alexoff D; Fowler JS; Thanos PK; Wong C; Casado V; Ferre S; Tomasi D
Transl Psychiatry; 2015 Apr; 5(4):e549. PubMed ID: 25871974
[TBL] [Abstract][Full Text] [Related]
20. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
